SAN DIEGO (AP) — SAN DIEGO (AP) — ImmunityBio, Inc. (IBRX) on Tuesday reported a loss of $92.6 million in its second quarter.
The San Diego-based company said it had a loss of 10 cents per share.
The results met Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was also for a loss of 10 cents per share.
The immunotherapy company posted revenue of $26.4 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IBRX at https://www.zacks.com/ap/IBRX
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
